Advertisement

Pharmacy

Home Pharmacy
Ibrance (palbociclib) has been approved by the U.S. Food and Drug Administration to treat advanced breast cancer among postmenopausal women.

FDA Approves Ibrance to Treat Advanced Breast Cancer

For postmenopausal women with ER+, HER2− metastatic breast cancer

Women Remain Underrepresented in Clinical Trials

Gap seen in cardiovascular, psychiatry, and cancer trial participation versus national prevalence disease data

Just a week after being declared Ebola-free

New Ebola Outbreak in Congo

Currently, 26 suspected cases of Ebola, including 20 deaths
In obese subjects with and without type 2 diabetes mellitus

Oxyntomodulin Augments Glucose Homeostasis

OXM effects seen in obese patients with and without T2DM; comparable effects to liraglutide in T2DM
Resting-state functional brain connectivity magnetic resonance imaging can predict response to psychotherapy in major depressive disorder

Resting-State Connectivity Predicts Psychotherapy Response

Pretreatment connectivity can predict response to psychotherapy in major depressive disorder

Biden Plan Will Spend $1.5 Billion to Boost Health Worker Supply

The pandemic has exacerbated health care disparities for minorities and underserved communities

There is little evidence supporting the efficacy of prophylactic pharmacologic treatments for pediatric migraine

Prophylactic Migraine Treatment Has No Effect in Children

Findings based on review of 23 studies with variety of treatments compared with placebo
The safety of the 9-valent human papillomavirus vaccine has been confirmed

Studies Confirm Safety of 9-Valent HPV Vaccination

Studies based on searching Vaccine Adverse Event Reporting System, six Vaccine Safety Datalink sites

Nearly Half of U.S. COVID-19 Cases Now Caused by JN.1 Variant

The speed at which the JN.1 variant has spread this month suggests it may spread more easily and be better at evading immune system